Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

An Antibody Uniquely Binding Short 2'-O-Methyl RNA Oligonucleotide Duplexes: Formation and Recognition of Target Duplexes on Cell Surfaces

Provisionally accepted
IAN  Seymour DUNNIAN Seymour DUNN1*Matthew  M. LawlerMatthew M. Lawler1Leah  FagundesLeah Fagundes1Milto  Simoes JuniorMilto Simoes Junior1April  MangoldApril Mangold1Domenic  RinaldiDomenic Rinaldi1Lenora  B. RoseLenora B. Rose1James  T. KurnickJames T. Kurnick2
  • 1TriBiotica LLC, Beverly, United States
  • 2Massachusetts General Hospital, Boston, United States

The final, formatted version of the article will be published soon.

With the primary aim of generating antibody tools useful for diagnostic and therapeutic applications relevant to oligonucleotide-templated reactions, an scFv filamentous phage library was screened using a specific 2'-O-methyl RNA template : oligonucleotide click reaction complex as the target structure. Such an antibody would not be anticipated to recognize any natural biological molecules. Two promising candidate scFv clones were converted into human IgG1 antibodies for further characterization. Surprisingly, although the best antibody (IgG1-DS5) bound to the original selection complex, its recognition preference was shown to be directed towards short 2'-O-methyl RNA duplexes without click modifications. The IgG1-DS5 antibody showed no binding to the separate single strands comprising the recognized duplex, nor to corresponding duplexes with RNA or DNA template strands. Versions of the target 2'-O-methyl RNA duplex with divergent sequences were also not recognized by IgG1-DS5. The unexpected binding properties of IgG1-DS5 antibody were directed towards potential applications based on molecular proximity of tethered single strands. Initially, SKBr3 cells were coated with biotins by means of surface azide metabolic labeling with peracetylated N-azidoacetylmannosamine, followed by treatment with a click-reactive DBCO-PEG4-biotin compound. Subsequent cell treatment with tetravalent biotin-binding protein neutravidin [NAV]) carrying subsaturating levels of biotinylated 2'-O-methyl RNA target duplexes showed strong IgG1-DS5 staining on cell surfaces. These observations were extended with biotinylated anti-EGFR antibody linked with biotinylated 2'-O-methyl RNA single strands, also by means of NAV protein as an adaptor. Flow cytometry analysis showed that DS5 antibody binding was only obtained when combinations of separate preparations of antibodies carrying top and bottom target strands were applied sequentially to EGFR-positive cells. These results show that proximity-based surface-annealing of IgG1-DS5 antibody target single strands can act to define cell populations with a surface marker of sufficient density. Where IgG1-DS5 is derivatized with either a fluorescent moiety or a cytotoxic drug, this antibody may find application in diagnostic or therapeutic tumor targeting.

Keywords: 2'-O-methyl RNA binding, Cancer diagnosis and therapy, cell surface targets, short duplex recognition, Surface annealing, unique monoclonal antibody

Received: 08 Sep 2025; Accepted: 15 Dec 2025.

Copyright: © 2025 DUNN, Lawler, Fagundes, Simoes Junior, Mangold, Rinaldi, Rose and Kurnick. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: IAN Seymour DUNN

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.